Course and prognosis in patients > or = 70 years of age with congestive heart failure and normal versus abnormal left ventricular ejection fraction.
about
N-terminal proBNP and mortality in hospitalised patients with heart failure and preserved vs. reduced systolic function: data from the prospective Copenhagen Hospital Heart Failure Study (CHHF).Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS).Heart failure--concepts and significance. Birth of a prognostic modelUnderstanding results of trials in heart failure with preserved ejection fraction: remembering forgotten lessons and enduring principlesHeart failure prognostic modelChronic heart failure in the elderly: value of cardiopulmonary exercise testing in risk stratification.Ventilatory variables are strong prognostic markers in elderly patients with heart failure.Heart failure with preserved left ventricular systolic function: a hospital cohort studyAre women different than men? Aspects of heart failure in special populations: elderly women.Diastolic heart failure: a difficult problem in the elderly.The epidemiological enigma of heart failure with preserved systolic function.Prognostic value of systolic mitral annular velocity measured with Doppler tissue imaging in patients with chronic heart failure caused by left ventricular systolic dysfunction.Echocardiographic features and brain natriuretic peptides in patients presenting with heart failure and preserved systolic function.Diastolic heart failure. Paroxysmal or chronic?Diastolic heart failure: recognition, diagnosis and management.Effectiveness of beta-blocker therapy in daily practice patients with advanced chronic heart failure; is there an effect-modification by age?Discriminating clinical features of heart failure with preserved vs. reduced ejection fraction in the community.Nebivolol for heart failure in the elderly.Predictors of new-onset heart failure: differences in preserved versus reduced ejection fractionCarotid arterial stiffness and its relationship to exercise intolerance in older patients with heart failure and preserved ejection fraction.Outcomes in ambulatory chronic systolic and diastolic heart failure: a propensity score analysis.Association of diastolic dysfunction and outcomes in ambulatory older adults with chronic heart failureQuantitative evaluation of the amount of delayed myocardial enhancement as a predictor of systolic dysfunction.Predictors of mortality and hospitalization in women with heart failure in the Digitalis Investigation Group trial.The prognostic significance of heart failure with preserved left ventricular ejection fraction: a literature-based meta-analysis.Differences among geriatricians, general internists, and cardiologists in the care of patients with heart failure: a cautionary tale of quality assessment.Hospitalizations and Prognosis in Elderly Patients With Heart Failure and Preserved Ejection Fraction: Time to Treat the Whole Patient.Prognosis of patients with left ventricular diastolic pressure abnormality: a long-term survival study in patients without coronary artery disease.Prognostic value of pulsed tissue Doppler imaging for the assessment of left ventricular systolic function in patients with nonischemic dilated cardiomyopathy.Short-term residential cardiac rehabilitation reduces B-type natriuretic peptide.Hypertension in African Americans with heart failure: progression from hypertrophy to dilatation; perhaps not.Quality of life in older patients with systolic and diastolic heart failure.Characterization of health-related quality of life in heart failure patients with preserved versus low ejection fraction in CHARM.Prescription of beta-blockers in patients with advanced heart failure and preserved left ventricular ejection fraction. Clinical implications and survival.Clinical correlates of isolated left ventricular diastolic dysfunction among hospitalized older heart failure patients.Perindopril for elderly people with chronic heart failure: the PEP-CHF study. The PEP investigators.
P2860
Q30908647-D2060195-A742-420C-9983-CB107B9ACF25Q34383304-49B14FE1-8197-4628-AC2D-01E8798DF57FQ34481280-A5E5F2AC-6032-4FF7-BD50-85614E4FE01AQ34999474-5429C5EF-F9FF-47E0-803F-3E2D9841F0A7Q35084657-8BB5550F-ECF5-4594-8DF4-C05B29CF098AQ35374859-5E9AC1E8-AC47-430A-9552-A2412C7E69A2Q35580353-58032FC7-AAEF-4595-A839-001F9F09A8BAQ35584442-14FBBAE8-7E4D-48E1-9587-9E9B2BFB7191Q35586409-A5F50D6D-E835-4436-902E-501361BF1D35Q35629401-E2206E4C-6585-433B-A5D8-E8EBD37ECB70Q35676021-276FD32E-8768-4430-906B-DD3967300F91Q35770870-A03CF634-3D1B-4DC7-AF50-CD067B34F0DEQ35771726-970636C9-A4C0-49D6-9631-90F81E61C167Q35795481-057091A4-5B9B-4FB7-8F0F-2473175AEBFCQ35841585-96F548D4-6AE9-423A-A968-165600CDF1A1Q36025044-7FBF118B-B8F4-4E54-B737-2DA04C861594Q36489384-E14E6FB6-5818-4DD1-9A62-F57CB4640B28Q36815960-2FD69D80-C657-49FB-8FD2-0EAAF0D95129Q36993734-AAE5CA04-C737-48EE-8B6F-FB63661A799FQ37015838-44D66B5B-2498-4218-B2D2-7AF0C72B1555Q37066500-0EABBBC2-D28F-4EE3-9E8C-7EAC151958EEQ37066519-5CF2BFA4-27C9-40FB-95CE-8A2CFBD68DF6Q37239711-ED184201-3935-4B45-90D6-2E307C6FCDBEQ37349595-FF2B6B4C-E3FE-4BE0-9047-37316E3F75E0Q37572119-45D4E985-C86C-4ADC-BEB2-57AF6F439258Q39479491-2902FC71-D3E2-4D1F-B772-BFCC96123C8BQ42653822-C8AB8840-6F58-4D2B-9AFB-F44DD91F5E69Q44687635-B796158E-F9CD-4133-A368-7A0571F0D6C4Q44774765-3265A50D-ECB4-46D2-AB86-B2C736FECF53Q45983590-2C090733-1789-4993-944D-CF68916BAC2AQ46155867-DDD72B17-A8E6-46BD-BACF-31145C74696EQ48716160-3BB14164-0B8E-41FA-B423-2DEEDA99C701Q51772672-4E9E6E86-E32D-4B97-88D0-96D6C7884621Q51781716-377821AD-D3E6-4148-A991-0AC5EECD2560Q52021147-AAD56611-A9E3-436C-B2B0-B172FA42962DQ53515461-DFE8C447-C0AD-405B-9E51-B88E7BD870EC
P2860
Course and prognosis in patients > or = 70 years of age with congestive heart failure and normal versus abnormal left ventricular ejection fraction.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh
1997年學術文章
@zh-hant
name
Course and prognosis in patien ...... ventricular ejection fraction.
@en
type
label
Course and prognosis in patien ...... ventricular ejection fraction.
@en
prefLabel
Course and prognosis in patien ...... ventricular ejection fraction.
@en
P2093
P1476
Course and prognosis in patien ...... ventricular ejection fraction.
@en
P2093
P304
P356
10.1016/S0002-9149(96)00719-9
P407
P577
1997-01-01T00:00:00Z